Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Embecta Corp. (EMBC) Cash Flow Statement

Embecta Corp. (EMBC) generated $174.1M of operating cash flow over the twelve months to 2026-06-30, spent $9.5M on capital expenditure and had free cash flow of $164.6M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

EMBCEmbecta Corp.Follow EMBC — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
380.2M
P/E TTM
4.6
Dividend yield
6.9%
52-week
—
Next earnings
23 Nov, in 30 days
LineFY2022
Sep 22
FY2023
Sep 23
FY2024
Sep 24
FY2025
Sep 25
TTM
Jun 26
Trend
Operating cash flow0.410.070.040.190.17
Capital expenditure0.020.030.020.01-0.01
Free cash flow0.390.040.020.180.16
Dividends paid0.010.030.030.04—
Stock-based compensation0.020.020.030.03—

USD billions · SEC XBRL

Embecta Corp. — questions

What is Embecta Corp.'s operating cash flow?
$174.1M over the twelve months to 2026-06-30.
How much does Embecta Corp. spend on capital expenditure?
$9.5M over the twelve months to 2026-06-30.
What is Embecta Corp.'s free cash flow?
$164.6M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Embecta Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.